相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Understanding the pharmacogenetic approach to warfarin dosing
Ingrid Glurich et al.
HEART FAILURE REVIEWS (2010)
Ability of VKORC1 and CYP2C9 to predict therapeutic warfarin dose during the initial weeks of therapy
N. S. Ferder et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2010)
Validation of Clinical Testing for Warfarin Sensitivity Comparison of CYP2C9-VKORC1 Genotyping Assays and Warfarin-Dosing Algorithms
Michael R. Langley et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2009)
CYP4F2 Is a Vitamin K1 Oxidase: An Explanation for Altered Warfarin Dose in Carriers of the V433M Variant
Matthew G. McDonald et al.
MOLECULAR PHARMACOLOGY (2009)
Estimation of the Warfarin Dose with Clinical and Pharmacogenetic Data
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Pharmacogenomics of anticoagulants: steps toward personal dosage
Ann K. Daly
GENOME MEDICINE (2009)
Performance of commercial platforms for rapid genotyping of polymorphisms affecting warfarin dose
Cristi R. King et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2008)
CYP4F2 genetic variant alters required warfarin dose
Michael D. Caldwell et al.
BLOOD (2008)
Pharmacology and management of the vitamin K antagonists
Jack Ansell et al.
CHEST (2008)
Warfarin pharmacogenetics
Nita A. Limdi et al.
PHARMACOTHERAPY (2008)
CYP2C9 genotype-guided warfarin prescribing enhances the efficacy and safety of anticoagulation:: A prospective randomized controlled study
Y. Caraco et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Randomized trial of genotype-guided versus standard warfarin dosing in patients initiating oral anticoagulation
Jeffrey L. Anderson et al.
CIRCULATION (2007)
Bleeding complications with warfarin use - A prevalent adverse effect resulting in regulatory action
Diane K. Wysowski et al.
ARCHIVES OF INTERNAL MEDICINE (2007)
Evaluation of Genetic Factors for Warfarin Dose Prediction
Michael D. Caldwell et al.
CLINICAL MEDICINE & RESEARCH (2007)
Prospective, Randomized Pilot Trial of Model-Based Warfarin Dose Initiation using CYP2C9 Genotype and Clinical Data
Michael A. Hillman et al.
CLINICAL MEDICINE & RESEARCH (2005)
The pharmacogenetics of coumarin therapy
D Voora et al.
PHARMACOGENOMICS (2005)
Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose
MJ Rieder et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Relative impact of covariates in prescribing warfarin according to CYP2C9 genotype
MA Hillman et al.
PHARMACOGENETICS (2004)
分享论文
